Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and ...

Vaxcyte, Inc.'s stock fell 50% despite positive vaccine results. See how FDA uncertainty, competition, and Phase 3 delays ...

This is exemplified in a 2021 speech by Yale Law School alumnus JD Vance titled “The Universities are the Enemy,” and has ...

Moderna Inc MRNA -11.5% Get Free Report shares were down 13.5% at $26.88 and Novavax Inc NVAX -9.02% Get Free Report shares ...

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...

Nearly every story about an American university could start with the caveat: “Most of the people mentioned in this article are either teenagers or at least somewhat crazy.” But, to borrow the parlance ...

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the COVID pandemic and has shown promise in addressing a ran ...

A top vaccine advisor at the FDA was forced to resign on Friday. In his resignation letter, Dr. Peter Marks, wrote "truth and ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.